Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 729,264 | 1,122,599 | 599,674 | 514,179 | 372,776 |
| Cost of Goods | 11,947 | 4,384 | 1,820 | N/A | N/A |
| Gross Profit | 717,317 | 1,118,215 | 597,854 | 514,179 | 372,776 |
| Operating Expenses | 890,346 | 752,716 | 660,046 | 483,132 | 392,936 |
| Operating Income | -172,082 | 365,883 | -61,372 | 31,047 | -20,160 |
| Interest Expense | 9,510 | 12,440 | 44,789 | 44,752 | 38,795 |
| Other Income | 47,040 | -14,677 | 30,005 | -3,058 | 1,489 |
| Pre-tax Income | -134,552 | 338,766 | -76,156 | -16,763 | -57,466 |
| Income Tax | 345,191 | 51,507 | -291,141 | -5,980 | 2,934 |
| Net Income Continuous | -479,743 | 287,259 | 214,985 | -10,783 | -60,400 |
| Minority Interests | -35,480 | 9,116 | -58,756 | N/A | N/A |
| Net Income | $-444,263 | $278,143 | $273,741 | $-10,783 | $-60,400 |
| EPS Basic Total Ops | -3.18 | 2.00 | 2.09 | 0.15 | -0.50 |
| EPS Basic Continuous Ops | -3.44 | 2.05 | 1.62 | -0.09 | -0.50 |
| EPS Diluted Total Ops | -3.18 | 1.90 | 2.07 | 0.15 | -0.50 |
| EPS Diluted Continuous Ops | -3.44 | 1.88 | 1.60 | -0.09 | -0.50 |
| EPS Diluted Before Non-Recurring Items | -3.23 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-140,146 | $377,337 | $-14,684 | $82,343 | $27,494 |